Patent-pending, Bayesian approach enables data-efficiency, uncertainty reasoning, and interpretability. Our engine is state-of-art for early diagnosis.

Bringing AI to medicine with causal inference and counterfactual reasoning.

Novel fluid- and digital-biomarkers, for the new era of real-world data and in-silico trials.